NEW YORK – Guardant Health announced Tuesday that its Guardant Reveal liquid biopsy test has received coverage from Medicare administrative contractor Palmetto GBA to monitor colorectal cancer ...

The targeting of telomeres offers promise for new cancer therapies, which can be aimed at disrupting the mechanisms that ...

The global immunoassay market size is estimated to grow by USD 9.4 billion from 2025 to 2029, according to Technavio. The market is estimated to grow at a CAGR of 4.6% during the forecast period. The ...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, announces the launch of its high-performance HPV IgG ELISA Kit for the sensitive and specific ...

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

KAUST Catalysis Center (KCC), Division of Physical Sciences & Engineering, King Abdullah University of Science and Technology, KAUST, Thuwal 23955, Kingdom of Saudi Arabia ...

Directing existing in-house synthetic biology capabilities to this project will create large-scale recombinant Antigens production to complement and expand Microbix’s addressable market share as a key ...

From published reports, a prioritized list ranking 75 tumor-associated vaccine antigens by these criteria is presented. Given the large number of potential tumor vaccine antigens, and the general ...

Biologic characterization of these latter antigens is based principally upon testing the antibodies produced in tumor-bearing hosts against the antigens of tumor cells. Another distinction may be made ...

Some experts believe cancer may one day be curable, while others think it's more likely we will learn to control it as a chronic disease rather than cure it outright. Either way, the many types cancer ...